Cite
APA Citation
Ribaldone, D. G., Manetta, T., Mengozzi, G., Saracco, G. M., Pellicano, R., & Astegiano, M. (2018). adalimumab trough levels predict Crohn's disease clinical course. Digestive and liver disease, 50(2), 204–206. http://access.bl.uk/ark:/81055/vdc_100056442269.0x000019